Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
2021 · Cancers · 288 citations
https://doi.org/10.3390/cancers13061383
E
Emilia Cocorocchio
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
130
Papers
3.0K
Citations
26
h-index
49
i10-index
Emilia Cocorocchio is an academic researcher from Humanitas Gavazzeni. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cutaneous Melanoma Detection and Management & Lymphoma Diagnosis and Treatment. The author has an h-index of 26, co-authored 111 publications.
ORCID: 0000-0003-1184-6426Papers by this author
worksBaseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients
2015 · British Journal of Cancer · 253 citations
https://doi.org/10.1038/bjc.2015.180
Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis
2017 · Critical Reviews in Oncology/Hematology · 119 citations
https://doi.org/10.1016/j.critrevonc.2017.12.003
A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma
2025 · Nature Biomedical Engineering · 37 citations
https://doi.org/10.1038/s41551-024-01318-z
Sex hormones, the anticancer immune response, and therapeutic opportunities
2025 · Cancer Cell · 22 citations
https://doi.org/10.1016/j.ccell.2025.02.013
Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer
2004 · Clinical Cancer Research · 16 citations
https://doi.org/10.1158/1078-0432.ccr-03-0453
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat